The work of Jocelyn Laporte and his team at IGBMC in Strasbourg, France, has recently been published in the high ranking journal, Nature. They are working on the reduction of a protein called DNM2, that is mutated in centronuclear myopathy. The reduction of this protein is proving beneficial in a number of forms of myotubular and centronuclear myopathy, and this publication demonstrates the promising nature of the progress to date. Read the article here

To read more about the work on DNM2 and the Myotubular Trust grant to IGBMC, read more here